Aprea Therapeutics Insider Trades

APRE

Track insider trading activity from Aprea Therapeutics executives and directors. See which insiders are buying and selling APRE stock.

Trades Last 12 Months

APRE Price

All Insider Trades for Aprea Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Hamill John P. Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $23.6k 30,978 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$47.3k 61,956 shares
$0.76
$0.76
Peters Richard Director
Holding Value $94.4k 123,915 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$189k 247,830 shares
$0.76
$0.76
Gilad Oren President/ceo
Holding Value $300k 393,895 shares
Last Trade
Mar 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.2k 100,875 shares
$0.76
$0.76
Duey Marc Director
Holding Value $195k 256,155 shares
Last Trade
Dec 10, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$40.4k 42,918 shares
$0.94
$0.76
Holding Value $7.79k 10,229 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.57k 4,185 shares
$1.81
$0.76
Gruia Gabriela Director
Holding Value $3.19k 4,185 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.57k 4,185 shares
$1.81
$0.76
Holding Value $3.19k 4,185 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.57k 4,185 shares
$1.81
$0.76
Pamukcu Rifat Director
Holding Value $4.15k 5,446 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.57k 4,185 shares
$1.81
$0.76
Holding Value $34.9k 45,775 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.57k 4,185 shares
$1.81
$0.76
Holding Value $3.19k 4,185 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.57k 4,185 shares
$1.81
$0.76
Mirza Nadeem Q. Chief Medical Officer
Holding Value $20.5k 26,920 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$141k 26,920 shares
$5.25
$0.76
Korbel Gregory Alan Svp, Chief Operating Officer
Holding Value $34.9k 45,762 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 60,000 shares
$21.80
$0.76
Coiante Scott M Svp, Chief Financial Officer
Holding Value $111k 145,065 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.27M 150,000 shares
$21.80
$0.76
Holding Value $198k 259,246 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$706k 32,400 shares
$21.80
$0.76
Abrahmsen Lars B. Svp, Chief Scientific Officer
Holding Value $76.2k 100,000 shares
Last Trade
Mar 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.54M 124,700 shares
$36.40
$0.76
Namouni Fouad Director
Holding Value $17.3k 22,750 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.67M 27,360 shares
$97.60
$0.76
Holding Value $3.51k 4,610 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.22M 22,750 shares
$97.60
$0.76
Attar Eyal C. Svp, Chief Medical Officer
Holding Value $25.1k 33,000 shares
Last Trade
Feb 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.2M 143,000 shares
$120.00
$0.76
Wessels Gregory S. Svp, Chief Commercial Officer
Holding Value $12.2k 16,000 shares
Last Trade
Feb 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.92M 66,000 shares
$120.00
$0.76
Redmile Group, Llc 10% owner
Holding Value $1.35M 1,768,718 shares
Last Trade
Dec 28, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$55M 500,000 shares
$110.00
$0.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up